aod9604 clinical trials efficacy side effects fat loss AOD-9604 Before and After: Results AOD-9604 Safety Profile: What Clinical
Description
Adding 2ml creates 1mg/ml (1000mcg/ml)
Mice treated with MOTS-c prevented diet-induced obesity and reversed insulin resistance
B12 is not a thermogenic agent and does not suppress appetite in people who are not deficient
This clean safety profile contributed to the FDA granting GRAS (Generally Recognized As Safe) status for AOD-9604 as a food ingredient in 2007
Often paired with diet and exercise regimens for enhanced fat-loss results
Idiopathic neuropathy, prediabetes and the metabolic syndrome
